Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Momenta closes $37.19mm IPO

Executive Summary

About a week after it closed its $20.5mm Series C venture round in March, Momenta Pharmaceuticals filed for an $86.25mm initial public offering. The company revised the offering in May to bring in up to $74.9mm, but has since completed the offering of 6.2mm common shares (including the overallotment) priced at $6.50 each, netting $37.19mm.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies